Announcement on Progress in Repurchasing A-Shares
Filed with SSE · · 2 pages · Chinese
On 6ix: 6ix.com/news/jiangsu-hengrui-pharmaceuticals-co-ltdannouncement-on-progress-in-repurchasing-a-shares
Jiangsu Hengrui Pharmaceuticals Co., Ltd. on 6ix
Earlier from Jiangsu Hengrui Pharmaceuticals
- Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning A-Share Repurchase
- Announcement on Implementation Result of Shares Repurchase and Share Changes
- Indicative Announcement on Acceptance of Application for Drug Marketing Authorization
- Announcement on Obtaining Orphan Drug Designation from the US FDA
- Announcement on Obtaining Drug Registration Approval
Later from Jiangsu Hengrui Pharmaceuticals
- Notice on Convening the 1st Extraordinary General Meeting in 2026
- Announcement on Initial Repurchase of the Company's A-Shares
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Hengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596
- Jiangsu Hengrui Pharmaceuticals: Hengrui Pharma Announces EMA Validation of Marketing Authorisation Application for Wevdury (fuzuloparib) in Combination with Abiraterone for Metastatic Castration-Resistant Prostate Cancer
Follow Jiangsu Hengrui Pharmaceuticals into a list and get an email when it puts out news.
Follow Jiangsu Hengrui Pharmaceuticals